Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

EFFECTS OF SMALL-SIDED GAME MANIPULATIONS ON NEUROMUSCULAR FATIGUE, PHYSIOLOGICAL RESPONSES, PHYSICAL PERFORMANCE, AND TECHNICAL SKILLS IN FEMALE FOOTBALL PLAYERS

24 de septiembre de 2026 actualizado por: Bilal GÖK, Istanbul Gelisim University

THE EFFECT OF MANIPULATIONS APPLIED IN SMALL-SIDED GAMES ON NEUROMUSCULAR FATIGUE, PHYSIOLOGICAL, PHYSICAL AND TECHNICAL PARAMETERS IN FEMALE FOOTBALLERS

Small-sided games will represent a prevalent component of branch-specific training methodologies in football. The objective of this study will be to examine the impact of small-sided games with sprint manipulation played in a 3v3 configuration on neuromuscular fatigue, along with physical, physiological, and technical parameters, in female football players.

The study will be conducted on a group of 12 female football players (experimental: 6, control: 6) who will have been actively playing licensed football for a minimum of three years. The participants will be asked to record their performance data over a six-week period, during which their physiological and physical parameters will be measured using Catapult (GPS) systems. The degree of neuromuscular fatigue will be determined through the active vertical jump test.

The data obtained from the study will be analysed using a Repeated Measures ANOVA test, with the significance level set at p < 0.05. Data analysis will be performed using the JASP 0.19.2 software package. It is expected that the results will reveal statistically significant differences in physiological parameters such as player load and perceived exertion level. In physical parameters, statistically significant differences are anticipated in total distance, positive acceleration, vertical jump performance, and running speed zones 1-2-3-4 (p < 0.05).

Consequently, the present study will aim to demonstrate that coaches may utilise this information in the organisation of training programmes to enhance performance parameters such as total distance covered, positive acceleration, and velocity, while simultaneously reducing neuromuscular fatigue in female football players.

Descripción general del estudio

Estado

Terminado

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Actual)

12

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 23 años (Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Femenino

Descripción

Inclusion Criteria:

Participants must be between the ages of 18 and 25. Participants must have played football at least three times. Participants must not have any health issues. Participants must voluntarily take part in the study.

Exclusion Criteria:

Participants not being between the ages of 18 and 25. Participants not having played licensed football for at least three years. Participants having a health issue.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Arm 1 (Experimental)

Sprint

In the study, the experimental group was exposed to sprint manipulation, unlike the control group.

Otro: Arm 2 (Control)

In the study, unlike the experimental group, the control group was given a 10-second recovery period.

In the study, unlike the experimental group, the control group was given a 10-second recovery period.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Neuromuscular Fatigue (Active Vertical Jump Height)
Periodo de tiempo: Baseline (pre-test), Week 3 (mid-test), and Week 6 (post-test)

Neuromuscular fatigue was assessed using the Active Vertical Jump Test (AVJT). Jump height was recorded in centimeters (cm) using a ForceDecks force platform. Each participant performed three trials with a two-minute rest between attempts, following a standardized warm-up protocol.

Baseline (pre-test), Week 3 (mid-test), and Week 6 (post-test)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Perceived Exertion Level
Periodo de tiempo: Baseline, Week 3, and Week 6

Perceived exertion was assessed using the Borg CR-10 Perceived Exertion Scale, scored from 1 (lowest) to 10 (highest), recorded 30 minutes after each training session.

Baseline, Week 3, and Week 6
Change in Maximum Heart Rate
Periodo de tiempo: Baseline, Week 3, and Week 6

Maximum heart rate was recorded using the Polar Team Pro GPS system, expressed in beats per minute (bpm).

Baseline, Week 3, and Week 6
Change in Estimated Maximal Oxygen Uptake (VO2max)
Periodo de tiempo: Baseline, Week 3, and Week 6

Aerobic capacity was estimated using the 30-15 Intermittent Fitness Test (Buchheit formula), expressed in ml/kg/min.

Baseline, Week 3, and Week 6
Change in Positive Acceleration
Periodo de tiempo: Baseline, Week 3, and Week 6

Positive acceleration was recorded using the Polar Team Pro GPS system, expressed in meters per second squared (m/s²).

Baseline, Week 3, and Week 6
Change in Sprint Distance
Periodo de tiempo: Baseline, Week 3, and Week 6

Sprint distance was recorded using the Polar Team Pro GPS system, expressed in meters (m).

Baseline, Week 3, and Week 6
Change in Distance Covered per Running Speed Zone
Periodo de tiempo: Baseline, Week 3, and Week 6

Distance covered was categorized into five speed zones using the Polar Team Pro GPS system: Zone 1 (0-6 km/h), Zone 2 (6.1-12 km/h), Zone 3 (12.1-15.4 km/h), Zone 4 (15.5-18.3 km/h), and Zone 5 (>18.4 km/h), expressed in meters (m).

Baseline, Week 3, and Week 6
Change in Player Load
Periodo de tiempo: Baseline, Week 3, and Week 6

Player load, a composite measure of physical demand, was recorded using the Polar Team Pro GPS tracking system, expressed in arbitrary units (AU).

Baseline, Week 3, and Week 6
Change in Total Distance Covered
Periodo de tiempo: Baseline, Week 3, and Week 6

Total distance covered during small-sided games was recorded using the Polar Team Pro GPS system, expressed in meters (m).

Baseline, Week 3, and Week 6
Change in Technical Performance Parameters
Periodo de tiempo: Baseline, Week 3, and Week 6

Technical performance (accurate passes, inaccurate passes, dribbles, one-on-one battles, feints, and ball losses) was recorded via video analysis (GoPro Hero 12 Black) using computerized notational coding, expressed as count of actions.

Baseline, Week 3, and Week 6

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

20 de marzo de 2024

Finalización primaria (Actual)

5 de enero de 2025

Finalización del estudio (Actual)

28 de abril de 2025

Fechas de registro del estudio

Enviado por primera vez

7 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

24 de septiembre de 2026

Publicado por primera vez (Actual)

28 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

28 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

24 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • 2024-01-107

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir